|Mr. Mark A. Augusti||CEO, Pres & Director||989.4k||N/A||1966|
|Mr. Robert S Howe||CFO & Treasurer||552.29k||N/A||1970|
|Mr. J. Brent Alldredge J.D.||Chief Legal Officer & Corp. Sec.||470.5k||N/A||1975|
|Mr. Gary Maingot||Sr. VP of Operations||N/A||N/A||N/A|
|Mr. John Slamin||Chief Technology Officer||N/A||N/A||1954|
|Mr. Farzin Khaghani||VP of U.S. Marketing||N/A||N/A||N/A|
|Ms. Allison Baker||Director of HR||N/A||N/A||N/A|
|Mr. Emmanuel O. Nyakako||Sr. VP of Quality & Regulatory Affairs||N/A||N/A||N/A|
|Eric Rickenbach||Sr. VP of US Sales||N/A||N/A||N/A|
|Mr. Terrance Wong||Sr. VP of HIP & Private Label Engineering||N/A||N/A||N/A|
Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee; and iTotal Identity, a knee system. It also provides Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Argentina, the United Arab Emirates, the Sultanate of Oman, Italy, San Marino, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
Conformis, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.